Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice

With the increasing use of immune-checkpoint inhibitors (ICIs), such as anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and anti-programmed cell death-1 (PD-1), for the treatment of malignancies, cases of ICI-induced type 1 diabetes mellitus (ICI-T1DM) have been reported globally. This rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yun Kyung, Jung, Chang Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695719/
https://www.ncbi.nlm.nih.gov/pubmed/37482654
http://dx.doi.org/10.4093/dmj.2023.0072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695719/
https://www.ncbi.nlm.nih.gov/pubmed/37482654
http://dx.doi.org/10.4093/dmj.2023.0072

Ejemplares similares